Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
8 likes 12mo
Regional · North America · continued
Canadian access and provincial variation — one year on posts 31–48
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
d.fontaine, post #12: Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community. Go to post
Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it is regulated.
post #32 answers the question as asked. The question underneath it is different.
Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
0 likes 12mo
United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans, not nationally.
12 likes 12mo
s.lundgren, post #22: post #21 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post
Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised. Current compounding availability is limited.
Worth separating two things that post #34 runs together.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
2 likes 12mo
Picking up post #36: that is the part I would want checked first.
Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
18 likes 12mo
Coming back to post #38, because the follow-up matters more than the original answer.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
0 likes 12mo
crossover_review, post #3: Coming back to the opening post, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive. Go to post
Two things before anyone answers the substance.
First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.
glossary_desk, post #35: United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans, not nationally. Go to post
This follows post #39 rather than contradicting it.
Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
23 likes 12mo
Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
10 likes 12mo
i.balogun, post #8: I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient. Go to post
Coming back to post #43, because the follow-up matters more than the original answer.
United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans, not nationally.
Picking up post #43: that is the part I would want checked first.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
1 like 12mo
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
|
+3 | 7 | 43k | 9mo |
|
[2026 update] US compounding rules and how they changed
US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category expires.…
|
+32 | 37 | 7.4k | 10mo |
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+46 | 50 | 7.9k | 5mo |
|
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
4 | 62k | 9mo | |
|
State-level differences that actually matter
On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
|
+6 | 10 | 56k | 10mo |
Related topics — sharing the tags FDA, compounding, insurance
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Reading a regulatory notice rather than an article about it
Posting this under the heading it deserves: Reading a regulatory notice rather than an article about it Everything below is what sits behind that. Structured report rather than an opinion, following the…
|
2 | 2.9k | 5mo | |
|
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+74 | 80 | 7.7k | 18mo |
|
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+5 | 9 | 45k | 4mo |
|
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
|
+3 | 7 | 43k | 9mo |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
|
3 | 60k | 12mo |